Loading stock data...

Kretto Syscon Limited

BSE: KRETTOSYS

BSE
1.27 0.00 (0.00%)

Prev Close

1.27

Open Price

1.27

Volume

5,200,295

Today Low / High

1.21 / 1.33

52 WK Low / High

0.87037 / 2.51852

Range

1 - 1

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 1.27, reflecting a change of 0 (0%). The expected target range on the BSE is 1 - 1. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

07 Oct 1.27 0.00%
06 Oct 1.34 -5.22%
03 Oct 1.31 1.53%
01 Oct 1.12 8.04%
30 Sep 1.15 -3.48%
29 Sep 1.15 0.00%
26 Sep 1.25 -8.00%
25 Sep 1.34 -5.22%
24 Sep 1.33 -2.26%
23 Sep 1.37 -4.38%
22 Sep 1.44 -4.17%
19 Sep 1.32 4.55%
18 Sep 1.45 -8.97%
17 Sep 1.49 -4.03%
16 Sep 1.50 -1.33%
15 Sep 1.41 4.26%
12 Sep 1.50 -4.67%
11 Sep 1.47 0.00%
10 Sep 1.51 -0.66%
09 Sep 1.63 -8.59%

Kretto Syscon Limited Graph

Kretto Syscon Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Kretto Syscon Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 1.27, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 1.27 1.28 1.15 - 1.41
1.30 1.04 - 1.55
1.31 0.92 - 1.70
Bearish Scenario 1.27 1.26 1.13 - 1.38
1.24 1.00 - 1.49
1.23 0.86 - 1.60

Overview of Kretto Syscon Limited

ISIN

INE128R01023

Industry

Medical - Specialties

Vol.Avg

4,199,891

Market Cap

868,386,922

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

0.58

DCF

1

Financial Ratios Every Investor Needs

Stock Rating Details for KRETTOSYS

Metric Value Recommendation
Overall Rating B- Sell
DCF Score 3 Neutral
ROE Score 3 Neutral
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 3 Neutral
Price-to-Book (PB) Score 3 Neutral

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 10.97 Cr 4.98 Cr 5.99 Cr 0.5461 0.00 Cr 0.20 Cr 4.89 Cr 4.13 Cr 0.07 5.59 Cr 0.3766
2024-03-31 0.00 Cr 0.01 Cr -0.01 Cr 0.0000 0.00 Cr 0.11 Cr -0.36 Cr 0.25 Cr 0.01 0.36 Cr 0.0000
2023-03-31 0.00 Cr 0.01 Cr -0.01 Cr 0.0000 0.00 Cr 0.01 Cr -0.37 Cr 0.19 Cr 0.01 0.26 Cr 0.0000
2022-03-31 3.48 Cr 3.54 Cr -0.06 Cr -0.0170 0.00 Cr 0.01 Cr -0.43 Cr 0.18 Cr 0.01 0.25 Cr 0.0514
2021-03-31 0.00 Cr 0.02 Cr -0.02 Cr 0.0000 0.00 Cr 0.01 Cr -0.49 Cr 0.12 Cr 0.00 0.18 Cr 0.0000

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 3.56 Cr 70.53 Cr 2.65 Cr 67.8756 Cr 1.01 Cr -2.55 Cr 0.00 Cr 0.76 Cr 0.00 Cr 0.00 Cr 1.86 Cr 1.6427 Cr
2024-03-31 0.00 Cr 18.52 Cr 1.81 Cr 16.7113 Cr 1.02 Cr 1.01 Cr 0.00 Cr 0.74 Cr 0.00 Cr 0.00 Cr 17.71 Cr 1.8110 Cr
2023-03-31 0.01 Cr 17.56 Cr 1.10 Cr 16.4606 Cr 0.00 Cr -0.01 Cr -0.02 Cr 0.74 Cr 0.00 Cr 0.00 Cr 16.37 Cr 1.0979 Cr
2022-03-31 0.00 Cr 17.93 Cr 1.65 Cr 16.2814 Cr 0.00 Cr 0.00 Cr -0.02 Cr 0.73 Cr 0.00 Cr 0.00 Cr 16.90 Cr 1.6491 Cr
2021-03-31 0.00 Cr 17.46 Cr 1.36 Cr 16.1028 Cr 0.02 Cr 0.02 Cr 0.00 Cr 0.73 Cr 0.05 Cr 0.00 Cr 16.55 Cr 1.3571 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -3.2944 Cr -40.2238 Cr 47.0343 Cr -3.3227 Cr 3.5159 Cr 3.5556 Cr -0.0283 Cr 4.1329 Cr -0.0051 Cr 0.0000 Cr 0.0000 Cr
2024-03-31 -0.3883 Cr -1.3466 Cr 1.0151 Cr -0.3883 Cr -0.3883 Cr 0.0397 Cr 0.0000 Cr 0.2541 Cr 1.0151 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 0.1704 Cr -0.0162 Cr 0.0000 Cr 0.1543 Cr 0.1543 Cr 0.4279 Cr -0.0162 Cr 0.2532 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2022-03-31 0.1297 Cr 0.0000 Cr -0.0220 Cr 0.1297 Cr 0.1077 Cr 0.2737 Cr 0.0000 Cr 0.2416 Cr -0.0220 Cr 0.0000 Cr 0.0000 Cr
2021-03-31 0.1400 Cr 0.0000 Cr 0.0000 Cr 0.1400 Cr 0.1400 Cr 0.1659 Cr 0.0000 Cr 0.1601 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 2.76 Cr 0.00 Cr 2.76 Cr 1.0000 1.91 Cr 2.09 Cr 0.03 2.10 Cr 0.7585
2025-03-31 2.29 Cr 3.91 Cr -1.62 Cr -0.7092 -2.25 Cr -1.36 Cr -0.02 -2.24 Cr -0.5931
2024-12-31 1.82 Cr 0.17 Cr 1.65 Cr 0.9057 1.32 Cr 0.98 Cr 0.02 1.32 Cr 0.5368
2024-09-30 5.83 Cr 0.46 Cr 5.36 Cr 0.9199 5.22 Cr 4.01 Cr 0.09 5.42 Cr 0.6880
2024-06-30 1.03 Cr 0.43 Cr 0.60 Cr 0.5810 0.57 Cr 0.68 Cr 0.02 0.68 Cr 0.6586

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 3.56 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -67.88 Cr
2025-03-31 3.56 Cr 0.00 Cr 3.56 Cr 7.59 Cr 0.00 Cr 11.86 Cr 0.76 Cr 70.53 Cr 2.65 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -21.22 Cr
2024-09-30 0.00 Cr 0.39 Cr 0.39 Cr 7.65 Cr 0.18 Cr 8.32 Cr 0.74 Cr 24.85 Cr 3.62 Cr
2024-06-30 0.00 Cr 0.00 Cr 0.04 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -16.71 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 2.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 -1.36 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.98 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 4.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 0.68 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2022-02-10 February 10, 22 10:1
2016-03-10 March 10, 16 7:5

Similar Stocks: Medical - Specialties

No stocks found in this industry.

Key Executives

Company Secretary & Compliance Officer
Ms. Manya Anup Khetwani

Gender: female

Year Born:

MD & Chairman
Mr. Tushar Shashikant Shah

Gender: male

Year Born: 1965

Chief Financial Officer & Director
Mr. Kush Bhadreshbhai Shah

Gender: male

Year Born:

FAQs about Kretto Syscon Limited

Who is the CEO of the company?

The CEO is Tushar Shashikant Shah.

What is the current market price of the stock?

The current price is ₹1.27.

What is the 52-week price range?

The range is ₹0.87037-2.51852.

What is the market capitalization of the company?

The market capitalization is ₹86.84 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 13.92.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Kretto Syscon Limited (ISIN: INE128R01023) is a leading Medical - Specialties in India. With a market capitalization of ₹86.84 crores and an average daily volume of 4,199,891 shares, it operates in the Medical - Specialties. The company last declared a dividend of ₹0.